Erythropoiesis is not equally suppressed in transfused males and females with β thalassemia major : are there clinical implications?
Blood transfusion in β thalassemia major aims to suppress ineffective erythropoiesis, limit morbidity from chronic anemia and minimise bone changes from marrow expansion and extramedullary hemopoiesis (EMH). 1 In the 1970s, blood transfusion was shown to suppress erythropoiesis. 2 It is uncertain how much blood should be transfused to each patient for optimal long-term health and to minimise complications. At present, all patients are transfused equally with no consideration given to gender. 3 There is limited data exploring differences between males and females. This study demonstrates important differences in pre-transfusion indices of erythropoiesis, descriptors of blood transfusion and the frequency of para-spinal EMH when patients are transfused according to current recommendations. These findings strongly support the notion that erythropoiesis is not being equally suppressed in males compared to females and hence that males are being under-transfused with current practices.
EMH is the presence of hemopoietic tissue outside of the bone marrow which occurs as a compensatory process in the setting of ineffective erythropoiesis. 1 Spinal cord compression is an uncommon but serious complication of para-spinal EMH. There is a clear male predominance (M:F ratio of ≥ 4:1) 4,5 that has been documented without drawing attention to gender differences or the possible need for males to be treated more intensively to avoid this complication. We aimed to determine by using readily available laboratory tests whether there were differences in erythropoietic activity between male and female adult β thalassemia major patients receiving a regular transfusion regimen in accordance with current international recommendations. 3 All 126 adults (≥18 years) with β thalassemia major at our centre were eligible. All patients had been receiving an individualised and regular transfusion regimen and iron chelation therapy in accordance with current recommendations. 3 Patients' height and weight were recorded to estimate blood volume using Nadler's formula. 6 Blood samples were collected on the day of, and prior to, routine transfusion when it was expected that erythropoietic activity would be
maximal. Blood samples were tested for hemoglobin (Hb), nucleated red blood cell (NRBC) and absolute and relative reticulocyte counts with a Beckman Coulter LH750 hematology analyzer.
Blood films were examined for manual NRBC and reticulocyte counts with a light microscope.
Serum ferritin and erythropoietin (EPO) levels were determined by immunoassay (Beckman Coulter DXi 800). We perform regular MRI at 1. One hundred and sixteen patients (51 males and 65 females) provided pre-transfusion blood samples ( Table 1 ). The 10 patients not included were either not available or declined testing.
Males and females were of similar ages and were receiving blood over a similar inter-transfusion interval. Males were heavier, taller and had a higher estimated blood volume. were the same, the interquartile ranges were different. However, when these values were corrected for weight, females were receiving a higher transfused volume per kg (225 ml/kg (188-263) vs males 202 (185-225), P = 0.028). The incidence of splenectomy was higher in males (61% vs 40% females, P = 0.031). The mean pre-transfusion Hb was 98-99g/l with no difference between males or females, thereby supporting our long-standing adherence to current recommendations ( Table 2) . 3 EPO levels were higher in males (72 mIU/ml (41-149) vs 52 (35-89), P = 0.006). NRBCs were higher in males with both manual (21 (2-98) vs 3 (1-28), P = 0.003) and automated counting (17 (0-54) vs 1 (0-20), P = 0.014). Males had higher absolute automated reticulocyte counts; however, there was no difference between manual reticulocyte counts.
Analysis of differences between males and females based on splenectomy status (Table 2) demonstrated that estimated annual transfusion volumes were higher in males. EPO levels were significantly higher in splenectomised males compared to females (77 mIU/ml (41-145) vs 48
(30-67), P = 0.01); however, this difference was not observed in non-splenectomised patients.
Ferritin levels were significantly higher in splenectomised females compared to males. There were no gender differences in Hb, reticulocyte or NRBC counts based on splenectomy status.
Six patients declined to have an MRI study. The incidence of para-spinal EMH was 13% (14/110). There were 11 cases in males and three cases in females (M:F ratio 3.66), resulting in an incidence in males and females of 22% (11/50) and 5% (3/60)(P = 0.01), respectively. There were no recent cases of epidural EMH with cord compression. Thirteen of the 14 patients with paraspinal EMH were splenectomised. An analysis excluding the 14 patients (11 males and 3 females) with EMH demonstrated that EPO levels remained significantly higher in males compared to females (Supplementary).
To our knowledge, this is the first report of a significant difference in EPO levels between males and females with β thalassemia major. EPO levels were higher comparing all males to all females and in splenectomised males versus splenectomised females. Higher EPO levels were not seen in non-splenectomised males versus females; however, the number of males in this analysis may have been too small to detect a small difference (n=20). Previous studies reporting no difference between males and females had small numbers of patients and had assessed or included β thalassemia intermedia patients. 7, 8 Cazzola et al 9 reported that the mean pretransfusion Hb was inversely related to EPO. Despite different reference ranges for Hb, there is no difference in the EPO reference range for men and women nor does it change with age. 10 The higher normal Hb levels in males compared to females results from the stimulation of erythropoiesis by androgens and its inhibition by oestrogens in females. 11 This suggests that males require a higher Hb level than females to achieve an equivalent suppression of erythropoiesis.
NRBCs were higher in males with automated and manual counting yet no difference was seen based on splenectomy status. Their presence in β thalassemia major reflects increased erythropoietic activity due to ineffective erythropoiesis; however, the clinical significance of the absolute numbers of NRBCs is not well understood. Although we report a difference in automated reticulocyte counts between males and females, the manual reticulocyte counts were not significantly different nor were there differences based on splenectomy status. RBC interference (e.g., target cells, Howell Jolly bodies, anisocytosis) in β thalassemia major samples makes it difficult to determine if a difference exists between the genders. 12 RBC interference and inter-observer variability contribute to the imprecision seen with manual reticulocyte counting.
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Despite males receiving a higher absolute annual blood volume, they received a lower estimated annual transfusion volume (ml/kg). Additionally, the incidence of splenectomy was higher in males, consistent with the notion that males have less effective suppression of erythropoiesis from blood transfusion with a consequent higher rate of ongoing splenomegaly compared to females. This is consistent with our previous data demonstrating that males had significantly increased pre-transfusion erythropoiesis and experienced a smaller post-transfusion reduction in erythropoiesis compared to females. 14 Although this may be biological, a potential limitation of this study is the different proportion of splenectomised males compared to females.
The predominance of males with para-spinal EMH (M:F ratio 3.66) is consistent with previous observations and has important clinical implications. Issargisil et al. 4 reviewed 12 cases and reported a male:female ratio of 5:1. Salehi et al. 5 reviewed 42 cases and reported a male:female ratio of approximately 4:1 (phenotype not specified). The natural history of EMH is poorly understood. As males and females are currently transfused equally, it is likely that the male predominance relates to the unequal suppression of erythropoiesis. Adequate transfusion to prevent para-spinal EMH is important as treatment options are not always effective if spinal cord compression has occurred. That all but one of our 14 patients with EMH had been splenectomised suggests that EMH and splenectomy status were independent markers of the adequacy of blood transfusion.
Our data strongly support the notion that erythropoiesis is not equally suppressed in males and females and that males are more prone to EMH with current transfusion practices. EPO may have a role in clinical practice for monitoring the suppression of erythropoiesis with transfusion.
The optimal pre-transfusion Hb required to adequately suppress erythropoiesis and prevent the development of EMH may be higher for males than females. Further work is needed to clarify and confirm these findings and to evaluate the need for consideration of gender when developing transfusion and monitoring protocols for patients with β thalassemia major.
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Methods
All androgen deficient males routinely receive testosterone replacement at our centre. Our
Hb reference ranges for males and females aged 13-55 are 130-180g/l and 120-160g/l, respectively. Each blood film was examined once.
Results
Assessment of genotype did not reveal a significant association with the indices of erythropoiesis (data not shown). Analyzer flagging (either for NRBCs and/or an abnormal reticulocyte pattern) occurred in 51% of all samples and was higher in males (62% vs 42%, P = 0.041), consistent with increased numbers of NRBCs and/or reticulocytes. To investigate if higher EPO levels in males could be attributable to the greater number of males with EMH, additional analyses were performed after excluding the 14 patients (11 males and 3 females) with EMH (Table 3) . Analysis of the remaining 102 patients (40 males and 62 females) demonstrated that EPO remained significantly higher in males versus fema les (67mIU/ml (40-145) vs 52 (35-89); P = 0.037). Automated and manual NRBC remained higher for males compared to females in this analysis. There was no significant difference in EPO between splenectomised males (n = 21) and females (n = 23)(66 mIU/mL (41-97) vs 44 (30-68); P = 0.11) or non-splenectomised males (n = 19) and females (n = 39)(75mIU/ml (38-173) vs 57 (39-93); P = 0.19); however, the numbers in this sub-analysis may have been too small to detect a small difference. Data are mean ± standard deviation or median (interquartile range). Transfused volumes are calculated on the assumption that each unit contains 260ml red cells (Australia Red Cross Blood Service red cell unit mean volume = 259 ± 23ml). 15 *Calculated using Nadler's formula for total blood volume (TBV): men TBV (ml) =
